Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cystic fibrosis
Pharma
Vertex wins FDA nod for once-daily cystic fibrosis triplet
As Vertex reels from a painful readout for its pain candidate, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis.
Angus Liu
Dec 23, 2024 10:58am
Vertex lifts sales guidance as Casgevy launch picks up
Aug 2, 2024 11:34am
Vertex inks long-term access deal for CF meds in England
Jun 21, 2024 11:31am
Vertex's Casgevy launch progresses as CF drugs post solid growth
May 7, 2024 11:23am
NICE rejects cost effectiveness of Vertex's cystic fibrosis meds
Nov 6, 2023 2:42pm
'The Top Line': 2022's top M&A deals and 2023's potential
Feb 10, 2023 6:00am
